Company intelligence / Profile preview

Resuscitation Therapeutics

North Chicago, Illinois, United States

Ownership: Private
Development stage: Other

Overview

Preparing IND submission for erythropoietin (EPO) to treat reperfusion injury during CPR for out-of-hospital cardiac arrest (OHCA), following favorable pre-IND FDA meeting and patent licensing; pivotal multi-center trial planned with primary outcome of 72-hour survival.

Therapeutic areas: Cardiovascular
Modalities: Hormone
Industry: Biotech

Beyond the preview

Go deeper on Resuscitation Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resuscitation Therapeutics.

Explore the full profile